Royalty Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	618.7	929.03	477.01	1,711	1,541
Short-Term Investments	18.8	58.2	18.3	25.72	647.87
Cash & Short-Term Investments	637.5	987.23	495.31	1,736	2,189
Cash Growth	-35.43%	99.31%	-71.48%	-20.67%	6.16%
Accounts Receivable	883.7	810.73	760.84	727.92	682.66
Receivables	883.7	810.73	760.84	727.92	682.66
Other Current Assets	6.89	4.19	18.04	90.52	6.63
Total Current Assets	1,528	1,802	1,274	2,555	2,878
Property, Plant & Equipment	19.1	-	-	-	-
Long-Term Investments	880.28	1,260	1,012	735.82	909.59
Goodwill	924.63	-	-	-	-
Other Intangible Assets	-	5.32	1.78	14.5	5.67
Long-Term Accounts Receivable	16,208	15,127	14,089	13,493	13,718
Other Long-Term Assets	60.19	28.21	4.74	15.13	4.14
Total Assets	19,621	18,223	16,382	16,813	17,516
Accounts Payable	19.4	13.37	15.17	7.91	5.62
Accrued Expenses	110.82	98.06	51.68	54.16	57.7
Current Portion of Long-Term Debt	380	997.77	-	997.51	-
Current Portion of Leases	3.16	-	-	-	-
Other Current Liabilities	122.83	144.41	94.53	107.2	107.93
Total Current Liabilities	636.21	1,254	161.38	1,167	171.25
Long-Term Debt	8,571	6,615	6,135	6,119	7,096
Long-Term Leases	16.1	-	-	-	-
Other Long-Term Liabilities	682.61	12.08	0.9	2.5	-
Total Liabilities	9,906	7,880	6,298	7,288	7,267
Common Stock	0.11	0.11	0.11	0.11	0.11
Additional Paid-In Capital	4,123	4,103	4,011	3,666	3,508
Retained Earnings	2,356	2,846	2,518	1,965	2,255
Treasury Stock	-2.61	-2.66	-2.63	-2.81	-2.72
Comprehensive Income & Other	-	-	-	-	16.49
Total Common Equity	6,477	6,947	6,526	5,628	5,777
Minority Interest	3,238	3,396	3,558	3,897	4,472
Shareholders' Equity	9,715	10,342	10,084	9,525	10,249
Total Liabilities & Equity	19,621	18,223	16,382	16,813	17,516
Total Debt	8,970	7,612	6,135	7,116	7,096
Net Cash (Debt)	-8,333	-6,625	-5,640	-5,380	-4,907
Net Cash Per Share	-14.76	-11.15	-9.35	-12.28	-11.83
Filing Date Shares Outstanding	428.42	433.32	446.69	443.17	432.96
Total Common Shares Outstanding	428.67	445.99	446.69	443.17	432.96
Working Capital	891.88	548.52	1,113	1,388	2,707
Book Value Per Share	15.11	15.58	14.61	12.70	13.34
Tangible Book Value	5,552	6,941	6,525	5,614	5,771
Tangible Book Value Per Share	12.95	15.56	14.61	12.67	13.33

Updated Feb 11, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q